378 related articles for article (PubMed ID: 14638914)
41. Mucin 4 Gene Silencing Reduces Oxidative Stress and Calcium Oxalate Crystal Formation in Renal Tubular Epithelial Cells Through the Extracellular Signal-Regulated Kinase Signaling Pathway in Nephrolithiasis Rat Model.
Sun L; Zou LX; Wang J; Chen T; Han YC; Zhu DD; Zhuo SC
Kidney Blood Press Res; 2018; 43(3):820-835. PubMed ID: 29843125
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of Autophagy Attenuated Ethylene Glycol Induced Crystals Deposition and Renal Injury in a Rat Model of Nephrolithiasis.
Liu Y; Liu Q; Wang X; He Z; Li D; Guan X; Tao Z; Deng Y
Kidney Blood Press Res; 2018; 43(1):246-255. PubMed ID: 29490299
[TBL] [Abstract][Full Text] [Related]
43. Peroxisome proliferator-activated receptor γ modulates renal crystal retention associated with high oxalate concentration by regulating tubular epithelial cellular transdifferentiation.
Li S; Lan Y; Wu W; Duan X; Kong Z; Wu W; Zeng G
J Cell Physiol; 2019 Mar; 234(3):2837-2850. PubMed ID: 30317563
[TBL] [Abstract][Full Text] [Related]
44. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
[TBL] [Abstract][Full Text] [Related]
45. Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture.
Verkoelen CF; van der Boom BG; Houtsmuller AB; Schröder FH; Romijn JC
Am J Physiol; 1998 May; 274(5):F958-65. PubMed ID: 9612335
[TBL] [Abstract][Full Text] [Related]
46. Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies.
Khan SR
Clin Exp Nephrol; 2004 Jun; 8(2):75-88. PubMed ID: 15235923
[TBL] [Abstract][Full Text] [Related]
47. Proposed mechanisms in renal tubular crystal retention.
Verkoelen CF; Verhulst A
Kidney Int; 2007 Jul; 72(1):13-8. PubMed ID: 17429341
[TBL] [Abstract][Full Text] [Related]
48. Renal cell osteopontin production is stimulated by calcium oxalate monohydrate crystals.
Lieske JC; Hammes MS; Hoyer JR; Toback FG
Kidney Int; 1997 Mar; 51(3):679-86. PubMed ID: 9067899
[TBL] [Abstract][Full Text] [Related]
49. Immuno-localization of CD44 and osteopontin in developing human kidney.
Crisi GM; Marconi SA; Rockwell GF; Braden GL; Campfield TJ
Pediatr Res; 2009 Jan; 65(1):79-84. PubMed ID: 18787423
[TBL] [Abstract][Full Text] [Related]
50. Atorvastatin Decreases Renal Calcium Oxalate Stone Deposits by Enhancing Renal Osteopontin Expression in Hyperoxaluric Stone-Forming Rats Fed a High-Fat Diet.
Liu CJ; Tsai YS; Huang HS
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328466
[TBL] [Abstract][Full Text] [Related]
51. Osteopontin and calcium stone formation.
Kleinman JG; Wesson JA; Hughes J
Nephron Physiol; 2004; 98(2):p43-7. PubMed ID: 15499214
[TBL] [Abstract][Full Text] [Related]
52. Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo.
Hong SH; Lee HJ; Sohn EJ; Ko HS; Shim BS; Ahn KS; Kim SH
Pharmacol Rep; 2013; 65(4):970-9. PubMed ID: 24145091
[TBL] [Abstract][Full Text] [Related]
53. Renal osteopontin expression in experimental urolithiasis.
Yagisawa T; Chandhoke PS; Fan J; Lucia S
J Endourol; 1998 Apr; 12(2):171-6. PubMed ID: 9607445
[TBL] [Abstract][Full Text] [Related]
54. Roles of and correlation between alpha-smooth muscle actin, CD44, hyaluronic acid and osteopontin in crescent formation in human glomerulonephritis.
Nakamura H; Kitazawa K; Honda H; Sugisaki T
Clin Nephrol; 2005 Dec; 64(6):401-11. PubMed ID: 16370152
[TBL] [Abstract][Full Text] [Related]
55. Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion.
Persy VP; Verstrepen WA; Ysebaert DK; De Greef KE; De Broe ME
Kidney Int; 1999 Aug; 56(2):601-11. PubMed ID: 10432399
[TBL] [Abstract][Full Text] [Related]
56. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage].
Toblli JE; Angerosa M; Stella I; Ferder L; Inserra F
Medicina (B Aires); 2003; 63(2):97-104. PubMed ID: 12793076
[TBL] [Abstract][Full Text] [Related]
57. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation?
de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; Schröder FH
Scanning Microsc; 1995 Mar; 9(1):103-14. PubMed ID: 8553009
[TBL] [Abstract][Full Text] [Related]
58. Histological observations of the adhesion and endocytosis of calcium oxalate crystals in MDCK cells and in rat and human kidney.
Ebisuno S; Kohjimoto Y; Tamura M; Inagaki T; Ohkawa T
Urol Int; 1997; 58(4):227-31. PubMed ID: 9253123
[TBL] [Abstract][Full Text] [Related]
59. Expression of CD44 in kidney after acute ischemic injury in rats.
Lewington AJ; Padanilam BJ; Martin DR; Hammerman MR
Am J Physiol Regul Integr Comp Physiol; 2000 Jan; 278(1):R247-54. PubMed ID: 10644646
[TBL] [Abstract][Full Text] [Related]
60. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
